Figure 5From: Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidaseTiter of ELISA for IgG antibody against PEG-uricase. The data shown are for the five subjects who showed early elimination of plasma uricase activity. PEG-uricase, PEG-modified recombinant mammalian urate oxidase.Back to article page